SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGPBiotechnology
+$0.45 today
- Market cap
- $993.14M
- Beta
- -0.34
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$1.32
Volume 0.10M
Average 0.09M
SGP Other Non-current Assets
Long-term assets not reported separately.
SpyGlass Pharma, Inc. Common StockNASDAQ: SGP
Other Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Other non-current assets of $789K in Q1 FY2026
Q1 FY2026 other non-current assets was $789K.
Context
- Other non-current assets amounted to 0.3% of total assets at the end of Q1 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 3.21M USD
- Year-over-year change
- —
| Period | Period end | Other Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.21M | — |
Other Non-current Assets vs competitors
How SGP compares with its peers on the latest reported figures
- Peers report in different currencies, so other non-current assets is compared through growth and share of total assets rather than absolute size.
- Other non-current assets amounts to 0.3% of total assets for SGP, versus a peer median of 1.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $424M USD | +6.4% | +26.5% | 1.4% | |
| Jun 2026 | $294M USD | -1.3% | +53.4% | 2.1% | |
| Apr 2026 | $35.54M USD | +86.3% | +12.2% | 7.9% | |
| Jun 2026 | $29.3M USD | +15.1% | +27.2% | 3.2% | |
| Mar 2026 | $18.94M USD | +214.2% | +365.4% | 6.6% | |
| Mar 2026 | $1.78M USD | +54.3% | -4.3% | 0.6% | |
| Mar 2026 | CHF 793.62K CHF | +56.2% | +119.8% | 0.3% | |
SGPSpyGlass Pharma, Inc. Common Stock | Mar 2026 | $789K USD | — | — | 0.3% |
| Mar 2026 | $370K USD | -21.6% | +34.9% | 0.3% | |
| Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| Peer median (excluding SGP) | — | +15.1% | +31.1% | 1.4% | |
Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGP
Intrinsic Alpha fair value
Locked
Current Price
$29.68
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.